Mesa laboratories inc /co (MLAB)
CashFlow / Yearly
Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11
Net income

7,484

-2,962

11,183

11,169

9,583

9,000

8,450

7,919

6,183

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

9,428

9,471

8,737

7,174

5,656

3,844

3,432

2,215

1,844

Stock-based compensation

4,212

1,672

1,411

1,327

993

840

1,112

464

383

Impairment loss on goodwill and long-lived assets

4,774

13,819

-

-

-

-

-

-

-

Gain on disposition of assets

288

116

-

0

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

0

-

-

-

-

-

Change in inventory reserve

380

-2,474

-194

-305

-

-

-

-

-

Gain on dispositions, net

-

-

-

-

-16

420

-

-

-

Deferred taxes

2,472

2,704

630

807

-450

43

291

258

414

Foreign currency adjustments

108

490

-93

-53

176

0

-

-

-

Impairment loss on goodwill

-

-

-

0

-

-

-

-

-

Adjustment to contingent consideration

-32

300

-

0

-

-

-

-

-

Other

-45

-110

-

-

-

-

-

-

-

Cash provided by changes in operating assets and liabilities
Accounts receivable, net

-1,592

-680

-994

1,958

2,291

-697

1,510

-493

931

Inventories, net

-2,574

-2,286

-101

1,507

3,164

1,300

228

-1,276

72

Prepaid expenses and other assets

2,898

-755

830

-391

-772

1,479

189

-38

-180

Accounts payable

1,092

212

-655

-150

410

754

437

-150

-1

Accrued liabilities and taxes payable

5,477

408

-3,066

2,865

-861

1,192

189

142

1,696

Unearned revenues

54

-196

-228

99

-572

308

-

-

-

Proceeds from disposition

-

-

-

-

-

661

-

-

-

Net cash provided by operating activities

30,554

25,719

17,304

16,903

10,816

12,373

11,402

12,489

8,868

Cash flows from investing activities:
Acquisitions

4,840

15,518

6,800

24,111

20,543

22,758

16,660

737

17,973

Proceeds from sale of assets

2,222

1,133

-

0

-

-

-

-

-

Purchases of property, plant and equipment

1,262

2,799

11,605

7,729

2,828

1,041

908

683

2,645

Net cash (used in) investing activities

-3,880

-17,184

-18,405

-31,840

-23,371

-23,138

-17,568

-1,420

-20,618

Cash flows from financing activities:
Proceeds from the issuance of debt

2,000

11,000

66,550

25,000

23,000

21,000

11,000

-

7,000

Payments on debt

25,625

19,625

57,000

6,000

13,250

8,500

7,000

6,500

778

Dividends

2,462

2,413

2,355

2,303

2,182

1,989

1,815

1,645

1,488

Impairment of intangible asset

-

-

-

-

-

-

-

350

-

Contingent Consideration

-680

-905

-9,554

-2,058

0

-1,020

-

-

-

Proceeds from the exercise of stock options

5,095

2,919

3,513

1,923

1,504

1,845

898

1,318

196

Net cash provided by (used in) financing activities

-21,672

-9,024

1,154

18,620

9,072

12,334

2,981

-7,424

4,825

Purchase and retirement of common stock

-

-

-

-

-

22

102

597

105

Effect of exchange rate changes on cash and cash equivalents

-286

138

72

-22

-58

0

-

-

-

Net increase in cash and cash equivalents

4,716

-351

125

3,661

-3,541

1,569

-3,185

3,645

-6,925

Income taxes

5,870

4,551

5,605

3,951

3,345

4,714

4,778

4,457

3,528

Interest

1,637

1,956

1,384

848

499

133

116

176

141

Contingent consideration as part of an acquisition

-

-

-

9,271

412

500

2,140

-

-

Employee loans issued for exercise of stock options

-

-

-

-

-

-

203

396

437

Repayment of employee loans for stock options

-

-

-

-

24

92

450

437

-